Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02476955
Title Open-label Phase 1b Study of ARQ 092 in Combination With Carboplatin Plus Paclitaxel
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors ArQule
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Grand Rapids Michigan 49503 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field